Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jilin Jichun Pharmaceutical is a comprehensive pharmaceutical enterprise based in Siping, Jilin Province, China, that integrates drug research, development, manufacturing, and marketing. The company is a leader in the industrialization of deer-based Traditional Chinese Medicine (TCM), leveraging local resources to produce specialized treatments for gynecological and tonic purposes. Its extensive product portfolio includes over 100 approved drugs across various forms such as capsules, tablets, and granules, targeting cardiovascular, respiratory, and digestive health. Recognized as a national high-tech enterprise, Jilin Jichun maintains modern GMP-certified facilities and has established a significant presence in the domestic Chinese market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 吉林吉春制药.